University of Alberta, Walter C. Mackenzie Health Sciences Centre (WMC)
Welcome,         Profile    Billing    Logout  
 4 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mason, Andrew L
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study

Recruiting
3
251
Europe, Canada, Japan, US, RoW
Linerixibat
GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited
Cholestasis
02/27
02/27
NCT03954327: Combination Antiretroviral Therapy (cART) for PBC

Completed
2
37
Canada
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Truvada, Raltegravir, Isentress, Placebo Oral Capsule [CEBOCAP], placebo
University of Alberta, Merck Sharp & Dohme LLC
Primary Biliary Cholangitis
10/22
01/24
PACIFIC, NCT05525520 / 2021-002526-25: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Completed
2
62
Europe, Canada, US, RoW
EP547, Placebo
Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc.
Pruritus
07/24
09/24
NCT03730454: Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair

Recruiting
N/A
150
US
Transanastomotic Tube (5FR), No Transanastomotic Tube
Phoenix Children's Hospital
Esophageal Atresia, Tracheoesophageal Fistula
02/25
02/25
CaNAL, NCT03569826: Canadian Network for Autoimmune Liver Disease

Recruiting
N/A
2500
Canada
Observational; no intervention
University Health Network, Toronto
Primary Bilary Cirrhosis (PBC), Autoimmune Hepatitis, Overlap Syndrome
12/28
12/28
NCT05608460: Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study

Recruiting
N/A
15700
US
University of Utah
Cervical Spine Fracture
08/25
08/25
Langkaas, Lee-Ann
ZYL-730-01, NCT05323019: Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression

Terminated
2
6
Canada
Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine), Spravato
Zylorion Health
Treatment Resistant Major Depressive Disorder
02/23
02/23
NCT06493461: A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

Recruiting
1
24
Europe, Canada
HS135
35Pharma Inc
Pulmonary Arterial Hypertension (PAH)
12/26
07/27
Hitchcock, Raelee
PACIFIC, NCT05525520 / 2021-002526-25: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Completed
2
62
Europe, Canada, US, RoW
EP547, Placebo
Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc.
Pruritus
07/24
09/24

Download Options